![]() |
Name |
Methyl 8-(2-octylcyclopropyl)octanoate
|
Molecular Formula | C20H38O2 | |
IUPAC Name* |
methyl 8-(2-octylcyclopropyl)octanoate
|
|
SMILES |
CCCCCCCCC1CC1CCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C20H38O2/c1-3-4-5-6-8-11-14-18-17-19(18)15-12-9-7-10-13-16-20(21)22-2/h18-19H,3-17H2,1-2H3
|
|
InChIKey |
WKDUVICSOMXTKJ-UHFFFAOYSA-N
|
|
Synonyms |
Methyl 8-(2-octylcyclopropyl)octanoate; Methyl dihydrosterculate; Cyclopropaneoctanoic acid, 2-octyl-, methyl ester; 10152-62-2; Methyl cis-9,10-methyleneoctadecanoate; SCHEMBL2505317; DTXSID20337562; methyl 9,10-methylene-octadecanoate; Methyl 8-(2-octylcyclopropyl)octanoate #; METHYLCIS-9,10-METHYLENEOCTADECANOATE
|
|
CAS | 10152-62-2 | |
PubChem CID | 543406 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 310.5 | ALogp: | 8.3 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 16 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 22 | QED Weighted: | 0.263 |
Caco-2 Permeability: | -4.781 | MDCK Permeability: | 0.00001590 |
Pgp-inhibitor: | 0.029 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.799 |
30% Bioavailability (F30%): | 0.991 |
Blood-Brain-Barrier Penetration (BBB): | 0.159 | Plasma Protein Binding (PPB): | 97.35% |
Volume Distribution (VD): | 2.587 | Fu: | 1.13% |
CYP1A2-inhibitor: | 0.32 | CYP1A2-substrate: | 0.218 |
CYP2C19-inhibitor: | 0.372 | CYP2C19-substrate: | 0.144 |
CYP2C9-inhibitor: | 0.267 | CYP2C9-substrate: | 0.924 |
CYP2D6-inhibitor: | 0.131 | CYP2D6-substrate: | 0.08 |
CYP3A4-inhibitor: | 0.703 | CYP3A4-substrate: | 0.119 |
Clearance (CL): | 5.999 | Half-life (T1/2): | 0.202 |
hERG Blockers: | 0.256 | Human Hepatotoxicity (H-HT): | 0.088 |
Drug-inuced Liver Injury (DILI): | 0.666 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.012 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.962 | Carcinogencity: | 0.048 |
Eye Corrosion: | 0.916 | Eye Irritation: | 0.943 |
Respiratory Toxicity: | 0.871 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003058 | ![]() |
0.750 | D0XN8C | ![]() |
0.488 | ||
ENC000604 | ![]() |
0.708 | D07ILQ | ![]() |
0.482 | ||
ENC000560 | ![]() |
0.701 | D0O1PH | ![]() |
0.449 | ||
ENC000271 | ![]() |
0.696 | D0Z5SM | ![]() |
0.444 | ||
ENC000495 | ![]() |
0.688 | D05ATI | ![]() |
0.429 | ||
ENC000496 | ![]() |
0.667 | D09ANG | ![]() |
0.398 | ||
ENC000260 | ![]() |
0.667 | D00FGR | ![]() |
0.380 | ||
ENC001682 | ![]() |
0.640 | D0T9TJ | ![]() |
0.376 | ||
ENC000280 | ![]() |
0.640 | D00MLW | ![]() |
0.374 | ||
ENC001657 | ![]() |
0.640 | D00AOJ | ![]() |
0.368 |